GLP-1 Medications and Medicare/Medicaid

It appears for now anyway Ozempic / Wegovy / Zepbound / Monjuro will not be covered by medicare:

Medicare and Medicaid won’t pay for popular obesity drugs like Wegovy and Zepbound, rejecting, at least for now, a Biden administration proposal that would have expanded coverage for weight loss

https://www.wsj.com/health/healthcare/trump-administration-rejects-expanding-medicare-medicaid-coverage-of-obesity-drugs-f32ced38?st=pZanPk&reflink=article_gmail_share